⌘K
t
| Date | 6 May 2022 |
| Time | 12:12:31 |
| Category | Director/PDMR dealings |
| ID | 6447K |
6 May 2022
Thruvision Group plc
("Thruvision" or the "Company")
Director Share Dealing-correction and further trade
Thruvision (AIM:THRU), the leading provider of "safe distance" people-screening technology to the international security market, provides an update to the announcement made on 20 April 2022 regarding the share purchase by Katrina Nurse, a Non-Executive Director of Thruvision, and her spouse, Mark Nurse, a Closely Associated Person.
In that announcement, it was stated that 67,000 Thruvision shares were purchased by each of Katrina Nurse and Mark Nurse at a price of 29.9p per share. The price was incorrectly stated and should have been reported as 32p per share.
In addition, Mark Nurse sold 9,591 Thruvision shares on 3 May 2022 at a price of 33.1p per share. This transaction was triggered by an automatic process within the fund in which the shares are held and was not intentional. Accordingly, Mark Nurse re-purchased 9,591 Thruvision shares on 4 May 2022 at a price of 33.5p per share.
Following these transactions, the beneficial shareholding in the Company of Katrina Nurse and her closely Associated Persons remains unchanged at 134,000 Thruvision shares, representing 0.09% of the Company's total issued share capital and total voting rights.
The notifications below, made in accordance with the requirements of the Market Abuse Regulation, provides further detail:
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
(a) |
Name |
Mark Nurse, spouse of Katrina Nurse |
|
|
2. |
Reason for the notification |
||
|
(a) |
Position/status |
Closely Associated Person of Katrina Nurse, a Non-Executive Director |
|
|
(b) |
Initial notification/ Amendment |
Initial notification |
|
|
3. |
Details of the issuer |
||
|
(a) |
Name |
Thruvision Group plc |
|
|
(b) |
LEI |
213800IZG9GM6G2TZE04 |
|
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
(a) |
Description of the Financial Instrument |
Ordinary shares of £0.01 each |
|
|
(b) |
Identification code of the Financial Instrument |
GB00B627R876 |
|
|
(c) |
Nature of the transaction |
Sale of shares
|
|
|
(d) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
|
|
33.1p |
9,591 |
|
|
|
|
|
|
(e) |
Aggregated information - Aggregated volume - Price |
N/A |
|
|
(f) |
Date of the transaction |
3 May 2022 |
|
|
(g) |
Place of the transaction |
London Stock Exchange |
|
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
(a) |
Name |
Mark Nurse, spouse of Katrina Nurse |
|
|
2. |
Reason for the notification |
||
|
(a) |
Position/status |
Closely Associated Person of Katrina Nurse, a Non-Executive Director |
|
|
(b) |
Initial notification/ Amendment |
Initial notification |
|
|
3. |
Details of the issuer |
||
|
(a) |
Name |
Thruvision Group plc |
|
|
(b) |
LEI |
213800IZG9GM6G2TZE04 |
|
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
(a) |
Description of the Financial Instrument |
Ordinary shares of £0.01 each |
|
|
(b) |
Identification code of the Financial Instrument |
GB00B627R876 |
|
|
(c) |
Nature of the transaction |
purchase of shares
|
|
|
(d) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
|
|
|
33.5p |
9,591 |
|
|
|
|
|
|
(e) |
Aggregated information - Aggregated volume - Price |
N/A |
|
|
(f) |
Date of the transaction |
4 May 2022 |
|
|
(g) |
Place of the transaction |
London Stock Exchange |
|
For further information please contact:
Thruvision Group plc +44 (0)1235 425400
Tom Black, Executive Chairman
Colin Evans, Chief Executive
Investec Investment Banking (NOMAD & Broker) +44 (0)20 7597 5970
Patrick Robb / James Rudd / Sebastian Lawrence
FTI Consulting LLP +44 (0)20 3727 1000
Matt Dixon
Tom Blundell
About Thruvision
Addressing the urgent need for "safe distance" people security screening in the COVID era, Thruvision is uniquely capable of detecting metallic and non-metallic items including weapons, explosives and contraband items that are hidden under clothing, at distances between 3 and 10m. Using patented passive terahertz technology, Thruvision completely removes the need for physical "pat-downs" and has been vetted and approved by the US Transportation Security Administration for surface transportation. Operationally deployed in 20 countries around the world, Thruvision is used for aviation security, retail supply chain loss prevention, customs and border control, and public area security. The company has offices near Oxford and Washington DC.